| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $188K | -2.0% | -56.3% |
| SG&A Expense | $527K | -5.2% | +1.2% |
| Operating Income | -$715K | +4.4% | +24.8% |
| Net Income | -$667K | +10.0% | +29.1% |
| EPS (Basic) | -$0.37 | +72.2% | +84.4% |
| EPS (Diluted) | -$0.37 | +72.2% | +84.4% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $6.4M | -9.3% | +56.2% |
| Total Assets | $6.4M | -9.3% | +56.2% |
| Current Liabilities | $334K | -17.7% | +22.3% |
| Total Liabilities | $334K | -17.7% | +22.3% |
| Stockholders' Equity | $6.0M | -8.8% | +58.6% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.0M | — | — |
| Financing Cash Flow | $4.7M | — | — |